Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Current Opinion in Immunology|March 27, 2018
Modulating ion channel function with antibodies and nanobodiesCatelijne Stortelers, Carolina Pinto-Espinoza, Diane Van Hoorick, et al.Antibodies (Basel, Switzerland)|September 24, 2019
Current Approaches and Future Perspectives for Nanobodies in Stroke Diagnostic and TherapyLarissa Jank, Carolina Pinto-Espinoza, Yinghui Duan, et al.Frontiers in Pharmacology|December 5, 2022
Origin, distribution, and function of three frequent coding polymorphisms in the gene for the human P2X7 ion channelWaldemar Schäfer, Tobias Stähler, Carolina Pinto Espinoza, et al.Frontiers in Immunology|September 7, 2021
A Methodological Approach Using rAAV Vectors Encoding Nanobody-Based Biologics to Evaluate ARTC2.2 and P2X7 <i>In Vivo</i>Henri Gondé, Mélanie Demeules, Romain Hardet, et al.Current Opinion in Pharmacology|April 16, 2019
Novel biologics targeting the P2X7 ion channelFriedrich Koch-Nolte, Anna Eichhoff, Carolina Pinto-Espinoza, et al.Frontiers in Oncology|October 12, 2020
Evaluation of P2X7 Receptor Function in Tumor Contexts Using rAAV Vector and Nanobodies (AAVnano)Mélanie Demeules, Allan Scarpitta, Catalina Abad, et al.Journal of Nanobiotechnology|January 11, 2024
Administration of an AAV vector coding for a P2X7-blocking nanobody-based biologic ameliorates colitis in miceCatalina Abad, Mélanie Demeules, Charlotte Guillou, et al.Journal of Neuroinflammation|October 12, 2022
Blocking P2X7 by intracerebroventricular injection of P2X7-specific nanobodies reduces stroke lesionsMaximilian Wilmes, Carolina Pinto Espinoza, Peter Ludewig, et al.European Journal of Immunology|September 30, 2022
P2X7 is expressed on human innate-like T lymphocytes and mediates susceptibility to ATP-induced cell deathRiekje Winzer, Arnau Serracant-Prat, Valerie J Brock, et al.Frontiers in Pharmacology|October 27, 2022
Effective targeting of microglial P2X7 following intracerebroventricular delivery of nanobodies and nanobody-encoding AAVsCarolina Pinto-Espinoza, Charlotte Guillou, Björn Rissiek, et al.Pageof 1